CEO and Executives Dump $60M After Record Rally

Key Takeaways

• CEO Jason Hollar offloaded 124,529 shares worth $29.4 million on August 18, marking his first open-market transaction since August 2025
• Combined insider sales from senior leadership totaled approximately $60 million in the wake of the earnings announcement
• Shares reached an all-time closing high of $240.26 on August 11 following fourth-quarter earnings per share of $2.91, surpassing expectations of $2.42
• The stock has retreated from its peak, opening Friday at $229.48 after touching an intraday high of $258.30
• Wall Street analysts hold a “Moderate Buy” rating with a mean price target of $266.56

---

In a significant move, Cardinal Health’s Chief Executive Officer Jason Hollar divested $29.4 million in CAH shares on August 18, mere days following the pharmaceutical distributor’s impressive performance that drove shares to unprecedented levels. The healthcare giant’s stock achieved a record closing price of $240.26 on August 11 and peaked intraday at $258.30.

Cardinal Health, Inc., CAH

Hollar’s transactions were completed within a price range of $234.07 to $238.065 per share. Notably, this represents his inaugural open-market disposition since August 2025 and merely his second stock sale since assuming leadership at Cardinal in 2020.

The CEO wasn’t operating in isolation. A coordinated series of stock sales by senior executives occurred simultaneously on the same date, collectively amounting to approximately $60 million in aggregate value.

Chief Financial Officer Aaron Alt disposed of 42,000 shares, generating proceeds exceeding $9.9 million. Jessica Mayer, serving as Chief Legal and Compliance Officer, sold 29,436 shares valued at nearly $7 million. Michelle Greene, the company’s Chief Information Officer, offloaded 11,650 shares for $2.7 million.

Division Leaders Join Selling Wave

Leadership of Cardinal’s primary operating divisions also participated in the stock reduction. Debbie Weitzman, who heads the pharmaceutical segment, sold 7,354 shares generating approximately $1.7 million. Steve Mason, leading the global medical products and distribution division, divested 35,000 shares worth roughly $8.3 million, dramatically reducing his ownership position by nearly 66%.

Mary Scherer, Chief Accounting Officer, sold 2,302 shares valued at approximately $546,472 on August 19. Collectively, company insiders disposed of 210,271 shares valued at nearly $49.6 million throughout the most recent quarter.

This selling activity followed Cardinal’s fourth-quarter financial results announced on August 11, which significantly exceeded projections. Earnings per share registered at $2.91, substantially above the consensus forecast of $2.42. Revenue climbed 5.8% on a year-over-year basis to $63.67 billion, although falling slightly below analyst projections of $65.15 billion.

Management also established fiscal year 2027 EPS guidance ranging from $12.40 to $12.60, providing additional momentum for the initial stock rally. Current analyst consensus forecasts full-year EPS at $12.54.

Wall Street Maintains Positive Outlook

Notwithstanding the stock retreat and executive selling activity, the broader investment community continues to express confidence in Cardinal’s prospects. TD Cowen elevated its price objective to $280 while reaffirming a “buy” recommendation. Leerink Partners established a $292 price target. Royal Bank of Canada launched coverage with an “outperform” designation and a $276 target.

JPMorgan increased its target from $215 to $260 while maintaining a “neutral” stance. Sixteen analysts recommend buying the stock, with three suggesting holding. The consensus price target stands at $266.56.

CAH commenced Friday trading at $229.48, representing a decline from its post-earnings peak. The 12-month low stands at $145.87. Cardinal has also announced a quarterly dividend distribution of $0.5158 per share, scheduled for October 15 payment to shareholders registered as of October 1, yielding 0.9%.

The post Cardinal Health (CAH) Stock: CEO and Executives Dump $60M After Record Rally appeared first on Blockonomi.

Source: https://blockonomi.com/cardinal-health-cah-stock-ceo-and-executives-dump-60m-after-record-rally/